glp 1 glucagon like peptide 1 Multiple physiologic effects of glucagon-like peptide-1 (GLP-1) GLP-1/Glucagon-Like Peptide, human - CPC

For adults over 65, no dose adjustment is required, but careful monitoring for adverse effects is prudent as older adults often have multiple comorbidities and medications that increase complication risk

It helps signal fullness, supports insulin release, slows stomach emptying, and helps regulate blood sugar

10.1111/appy.12120 88

In post hoc robustness analyses assessing the impact of competing risk of death, the risk ratios for thyroid cancer at five years of follow-up were 0.80 (0.58 to 1.14) with death as a censoring event and 0.82 (0.59 to 1.16) with death as a competing event

Niksarli told me

It's not the only tool